BM

Brian R. Murphy

US US Dept of Health & Human Services: 22 patents #13 of 3,044Top 1%
TA The United States Of America: 4 patents #2 of 521Top 1%
UA US Army: 3 patents #18 of 341Top 6%
SR Scripps Research: 3 patents #296 of 1,293Top 25%
SH St. Jude Children'S Research Hospital: 2 patents #108 of 351Top 35%
CF Cornell Research Foundation: 1 patents #802 of 1,638Top 50%
AP Amerimas Home Products: 1 patents #421 of 715Top 60%
📍 Bethesda, MD: #3 of 2,269 inventorsTop 1%
🗺 Maryland: #87 of 35,612 inventorsTop 1%
Overall (All Time): #22,387 of 4,157,543Top 1%
80
Patents All Time

Issued Patents All Time

Showing 51–75 of 80 patents

Patent #TitleCo-InventorsDate
7704509 Recovery of recombinant human parainfluenza virus type 1 (HPIV1) from cDNA and use of recombinant HPIV1 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens Peter L. Collins, Mario H. Skiadopoulos, Jason T. Newman 2010-04-27
7704491 Recombinant human metapneumovirus and its use Peter L. Collins, Stephane Biacchesi, Ursula Buchholz, Mario H. Skiadopoulos 2010-04-27
7662397 Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal genes Christine Krempl, Peter L. Collins, Ursula Buchholz, Stephen S. Whitehead 2010-02-16
7632508 Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines Alexander C. Schmidt, Mario H. Skiadopoulos, Peter L. Collins, Jane E. Bailly, Anna P. Durbin 2009-12-15
7622123 Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines Mario H. Skiadopoulos, Peter L. Collins, Alexander C. Schmidt 2009-11-24
7560118 Attenuated dengue virus comprising mutations in the NS3 gene Stephen S. Whitehead, Kathryn A. Hanley, Joseph E. Blaney 2009-07-14
7517531 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 Stephen S. Whitehead, Lewis Markoff, Barry Falgout, Joseph E. Blaney, Kathryn A. Hanley 2009-04-14
7488477 Neutralizing monoclonal antibodies to respiratory syncytial virus Glenn Pilkington, Page S. Gilmour, Robert M. Chanock, James E. Crowe, Jr. 2009-02-10
7485440 Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2 Peter L. Collins, Alison Bermingham 2009-02-03
7465794 Polynucleotides encoding recombinant respiratory syncytial viruses expressing immune modulatory molecules Peter L. Collins, Alexander Bukreyev, Stephen S. Whitehead 2008-12-16
7364737 Human neutralizing monoclonal antibodies to respiratory syncytial virus Dennis R. Burton, Carlos F. Barbas, III, Robert M. Chanock, James E. Crowe, Jr. 2008-04-29
7314631 Use of recombinant live-attenuated parainfluenza virus (PIV) as a vector to protect against disease caused by PIV and respiratory syncytial virus (RSV) Peter L. Collins, Anna P. Durbin, Mario H. Skiadopoulos, Tao Tao 2008-01-01
7250171 Construction and use of recombinant parainfluenza viruses expressing a chimeric glycoprotein Tao Tao, Mario H. Skiadopoulos, Peter L. Collins 2007-07-31
7226602 Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses Stephen S. Whitehead, Kathryn A. Hanley, Joseph E. Blaney 2007-06-05
7208161 Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences Peter L. Collins, Anna P. Durbin, Mario H. Skiadopoulos, Tao Tao 2007-04-24
7201907 Attenuated human-bovine chimeric parainfluenza virus(PIV) vaccines Alexander C. Schmidt, Mario H. Skiadopoulos, Peter L. Collins, Jane E. Bailly, Anna P. Durbin 2007-04-10
7192593 Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens Peter L. Collins, Alexander C. Schmidt, Anna P. Durbin, Mario H. Skiadopoulos, Tao Tao 2007-03-20
6923971 Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal genes Christine Krempl, Peter L. Collins, Ursula Buchholz, Stephen S. Whitehead 2005-08-02
6713066 Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2 Peter L. Collins, Alison Bermingham 2004-03-30
6689367 Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences Peter L. Collins, Stephen S. Whitehead 2004-02-10
6685942 Human neutralizing monoclonal antibodies to respiratory syncytial virus Dennis R. Burton, Carlos F. Barbas, III, Robert M. Chanock, James E. Crowe, Jr. 2004-02-03
6410023 Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of a non-essential gene Anna P. Durbin, Peter L. Collins 2002-06-25
6284254 Immunogenic compositions comprising cold-adapted attenuated respiratory syncytial virus mutants Robert M. Chanock, James E. Crowe, Jr., Mark Connors, Kuo-Hom L. Hsu, Alan R. Davis +2 more 2001-09-04
5993824 Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences Peter L. Collins, Stephen S. Whitehead, Alexander Bukreyev, Katalin Juhasz, Michael N. Teng 1999-11-30
5922326 Attenuated respiratory syncytial virus vaccine compositions Robert M. Chanock, James E. Crowe, Jr., Mark Connors 1999-07-13